Evidence map›Paper›PMID 35298359›Full record

ArticlePharmaceutical biology2022

Atsushi Haraguchi, Keisuke Saito, Yu Tahara, Shigenobu Shibata

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Saponin components inFrontiers in pharmacology · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Atsushi HaraguchiSchool of Advanced Science and Engineering, Laboratory of Physiology and Pharmacology, Waseda University, Tokyo, Japan.
Keisuke SaitoSchool of Advanced Science and Engineering, Laboratory of Physiology and Pharmacology, Waseda University, Tokyo, Japan.
Yu TaharaSchool of Advanced Science and Engineering, Laboratory of Physiology and Pharmacology, Waseda University, Tokyo, Japan.
Shigenobu ShibataSchool of Advanced Science and Engineering, Laboratory of Physiology and Pharmacology, Waseda University, Tokyo, Japan.
Waseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe mammalian circadian clock system regulates physiological function. Crude drugs, containing

objectiveWe examine effective crude drugs, which cover at least one or two of Kampō, for the shortening effects on period length of clock gene expression rhythm, and reveal the mechanism of shortening effects. MATERIALS AND

methodsWe prepared 40 crude drugs. In the

resultsWe found that DISCUSSION AND

conclusionsOur results indicate that

Indexed as

PolygalaAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Circadian ClocksDose-Response Relationship, DrugMaleMedicine, KampoMiceMice, Inbred C57BLMotor ActivityPlant ExtractsSignal TransductionCalcium-Calmodulin-Dependent Protein Kinase Type 2Plant Extractsclock gene expression rhythmCrude drugfree-running period lengthlocomotor activity rhythms

Identifiers

PMID35298359
PMCPMC8933028
OpenAlexW4221132106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.